On May 6, 2025, Barrington Research analyst Michael Petusky announced a revision in the price target for Henry Schein (HSIC, Financial), a leading provider of health care products and services. The firm adjusted the price target from $90.00 to $86.00 USD, indicating a decrease of 4.44%.
Despite the adjustment, the analyst maintained an 'Outperform' rating for the stock, consistent with the prior evaluation. This rating suggests that Henry Schein (HSIC, Financial) is expected to perform better than the market average in the future.
The adjustment in the price target for Henry Schein (HSIC, Financial) reflects Barrington Research's updated analysis, but the continued 'Outperform' rating indicates confidence in the company's potential market performance.
Wall Street Analysts Forecast
Based on the one-year price targets offered by 13 analysts, the average target price for Henry Schein Inc (HSIC, Financial) is $76.80 with a high estimate of $90.00 and a low estimate of $55.00. The average target implies an upside of 15.35% from the current price of $66.58. More detailed estimate data can be found on the Henry Schein Inc (HSIC) Forecast page.
Based on the consensus recommendation from 17 brokerage firms, Henry Schein Inc's (HSIC, Financial) average brokerage recommendation is currently 2.5, indicating "Outperform" status. The rating scale ranges from 1 to 5, where 1 signifies Strong Buy, and 5 denotes Sell.
Based on GuruFocus estimates, the estimated GF Value for Henry Schein Inc (HSIC, Financial) in one year is $83.97, suggesting a upside of 26.12% from the current price of $66.58. GF Value is GuruFocus' estimate of the fair value that the stock should be traded at. It is calculated based on the historical multiples the stock has traded at previously, as well as past business growth and the future estimates of the business' performance. More detailed data can be found on the Henry Schein Inc (HSIC) Summary page.
